Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Jan 13, 2014
HEMISPHERX BIOPHARMA TO PRESENT ON JANUARY 15 AT THE BIOTECH SHOWCASE HELD IN CONJUNCTION WITH THE 32nd JP MORGAN HEALTHCARE CONFERENCE IN SAN FRANCISCO
Jan 07, 2014
Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) – Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus
1
2
3
4
5
<<
<
>
>>
Privacy